Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAISE-AriSE: Low-dose Aripiprazole in PAIS/PCC
NCT07714213Phase 2Not yet recruiting
- Sponsor
- Christiana Franke
- Start
- Oct 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 2 trial of aripiprazole in post-infectious syndrome (PAIS), post-COVID-19 condition (PCC), sponsored by Christiana Franke. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
aripiprazole
03
Conditions
post-infectious syndrome (PAIS)post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT07714213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07714213.